Treating knee osteoarthritis with intra-articular hyaluronans

References

• Centers for Disease Control and Prevention. Prevalence of disabilities and associated health conditions among adults – United States, 1999. MMWR 2001;50:120-5
   PubMedGoogle Scholar
• Creamer P, Lethbridge-Cejku M, Hochberg MC. Factors associated with functional impairment in symptomatic knee osteoarthritis. Rheumatology 2000;39:490-6
   PubMed Web of Science ®Google Scholar
• Dillon CF, Rasch EK, Gu Q, et al. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. J Rheumatol 2006;33:2271-9
   PubMed Web of Science ®Google Scholar
• Horváth G, Than P, Bellyei Á, et al. Prevalence of degenerative joint complaints of the lower extremity: a representative study. Int Orthop 2006;30:118-22
   PubMed Web of Science ®Google Scholar
• Dawson J, Linsell L, Zondervan K, et al. Epidemiology of hip and knee pain and its impact on overall health status in older adults. Rheumatology 2004;43:497-504
   PubMed Web of Science ®Google Scholar
• DeFrances CJ, Hall MJ. 2005 national hospital discharge survey. Adv Data 2007;385:1-19
   PubMedGoogle Scholar
• MacLean CH, Knight K, Paulus H, et al. Costs attributable to osteoarthritis. J Rheumatol 1998;25:2213-18
   PubMed Web of Science ®Google Scholar
• American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 2000;43:1905-15
   PubMed Web of Science ®Google Scholar
• American Pain Society. Guidelines for the Management of Pain in Osteoarthritis. Glenview: American Pain Society, 2002
   Google Scholar
• Eyigor S, Hepguler S, Sezak M, et al. Effects of intra-articular hyaluronic acid and corticosteroid therapies on articular cartilage in experimental severe osteoarthritis. Clin Exp Rheumatol 2006;24:724
   PubMed Web of Science ®Google Scholar
• Kean WF, Rainsford KD, Kean IR. Management of chronic musculoskeletal pain in the elderly: opinions on oral medication use. Inflammopharmacology 2008;16:53-75
   PubMedGoogle Scholar
• Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 1998;25:2203-12
   PubMed Web of Science ®Google Scholar
• Carrabba MP, Paresce E, Angelini M, et al. The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm 1995;15:25-31
   Google Scholar
• Grecomoro G, Martorana U, Di Marco C. Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica 1987;5:137-41
   PubMedGoogle Scholar
• Huskisson EC, Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology 1999;38:602-7
   PubMed Web of Science ®Google Scholar
• Lohmander LS, Dalen N, Englund G, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 1996;55:424-31
   PubMed Web of Science ®Google Scholar
• Day R, Brooks P, Conaghan PG, et al. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol 2004;31:775-82
   PubMed Web of Science ®Google Scholar
• Brandt KD, Block JA, Michalski JP, et al. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop Relat Res 2001;130-43
   PubMed Web of Science ®Google Scholar
• Strand V, Conaghan PG, Lohmander LS, et al. An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-articular injection in osteoarthritis of the knee. Osteoarthritis Cartilage 2006;14:859-66
   PubMed Web of Science ®Google Scholar
• Wobig M, Dickhut A, Maier R, et al. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 1998;20:410-23
   PubMed Web of Science ®Google Scholar
• Scale D, Wobig M, Wolpert W. Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study. Curr Ther Res 1994;55:220-32
   Web of Science ®Google Scholar
• Dickson DJ, Hosie G, English JR. A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Clin Res 2001;4:41-52
   Google Scholar
• Henderson EB, Smith EC, Pegley F, et al. Intra-articular injections of 750 kDa hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis 1994;53:529-34
   PubMed Web of Science ®Google Scholar
• Karlsson J, Sjogren LS, Lohmander LS. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology 2002;41:1240-8
   Google Scholar
• Neustadt DH. Long-term efficacy and safety of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Clin Exp Rheumatol 2003;21:307-11
   PubMed Web of Science ®Google Scholar
• Tamir E, Robinson D, Koren R, et al. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee. A randomized, double blind, placebo controlled study. Clin Exp Rheumatol 2001;19:265-70
   PubMed Web of Science ®Google Scholar
• Lundsgaard C, Dufour N, Fallentin E, et al. Intra-articular sodium hyaluronate 2 mL versus physiological saline 20 mL versus physiological saline 2 mL for painful knee osteoarthritis: a randomized clinical trial. Scand J Rheumatol 2008;37:142-50
   PubMed Web of Science ®Google Scholar
• Dougados M, Nguyen M, Listrat V, et al. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1993;1:97-103
   PubMedGoogle Scholar
• Bellamy N, Campbell J, Robinson V, et al. Viscosupplementation for the treatment of osteoarthritis of the knee (review). Cochrane Database Syst Rev 2006; CD005321
   Web of Science ®Google Scholar
• Wang CT, Lin J, Chang CJ, et al. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004;86:538-45
   PubMed Web of Science ®Google Scholar
• Lo GH, LaValley M, McAlindon T, et al. Intra-articular hyaluronic acid in treatment of knee osteoarthritis. A meta-analysis. JAMA 2004;290:3115-21
   Web of Science ®Google Scholar
• Kirchner M, Marshall D. A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage 2006;14:154-62
   PubMed Web of Science ®Google Scholar
• Lussier A, Cividino AA, McFarlane CA, et al. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 1996;23:1579-85
   PubMed Web of Science ®Google Scholar
• Wobig M, Beks P, Dickhut A, et al. Open-label multicenter trial of the safety and efficacy of viscosupplementation with hylan G-F 20 (Synvisc) in primary osteoarthritis of the knee. J Clin Rheumatol 1999;5:24-31
   Web of Science ®Google Scholar
• Evanich JD, Evanich CJ, Wright MB, et al. Efficacy of intraarticular hyaluronic acid injections in knee osteoarthritis. Clin Orthop Relat Res 2001;390:173-81
   PubMedGoogle Scholar
• Waddell DD, Bricker D. Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee. J Knee Surg 2006;19:19-27
   PubMedGoogle Scholar
• Kemper F, Gebhardt U, Meng T, et al. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice. Curr Med Res Opin 2005;21:1261-9
   PubMed Web of Science ®Google Scholar
• Raynauld JP, Torrance G, Band P, et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage 2002;10:506-17
   PubMed Web of Science ®Google Scholar
• Kahan A, Lleu PL, Salin L. Prospective randomized study comparing the medico-economic benefits of hylan G-F 20 vs. conventional treatment in knee osteoarthritis. Joint Bone Spine 2003;70:276-81
   PubMed Web of Science ®Google Scholar
• Wobig M, Bach G, Beks P, et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower- molecular-weight hyaluronan. Clin Ther 1999;21:1549-62
   PubMed Web of Science ®Google Scholar
• Allen E, Krohn K. Adverse reactions to hylan GF-20. J Rheumatol 2000;27:1572
   PubMed Web of Science ®Google Scholar
• Disla E, Infante R, Fahmy A, et al. Recurrent acute calcium pyrophosphate dihydrate arthritis intraarticular hyaluronic injection. Arthritis Rheum 1999;42:1302-3
   PubMed Web of Science ®Google Scholar
• Kroesen S, Schmid W, Theiler R. Induction of an acute attack of calcium pyrophosphate dihydrate arthritis by intra-articular injection of hylan G-F 20 (Synvisc). Clin Rheumatol 2000;19:147-9
   PubMed Web of Science ®Google Scholar
• Bernardeau C, Bucki B, Lioté F. Acute arthritis after intra-articular hyaluronate injection: onset of effusions without crystal. Ann Rheum Dis 2001;60:518-20
   PubMed Web of Science ®Google Scholar
• Luzar MJ, Altawil B. Pseudogout following intraarticular injection of sodium hyaluronate. Arthritis Rheum 1998;41:939-41
   PubMed Web of Science ®Google Scholar
• Maillefert JF, Hirschhorn P, Pascaud F, et al. Acute attack of chondrocalcinosis after an intraarticular injection of hyaluronan. Rev Rhum Engl Ed 1997;64:593-4
   PubMedGoogle Scholar
• Mostefai S, Rahmani S, Bengana B, et al. Arthrite aiguë pseudo septique aprés injection intra-articulaire de hyaluronate de sodium. Rev du Rheum 2006;73:1100-1
   Google Scholar
• Zardawi IM, Chan I. Synvisc perisynovitis. Pathology 2001;33:519-20
   PubMed Web of Science ®Google Scholar
• Caborn D, Rush J, Lanzer W, et al. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol 2004;31:333-43
   PubMed Web of Science ®Google Scholar
• Frizziero L, Pasquali-Ronchetti I. Intra-articular treatment of osteoarthritis of the knee: an arthroscopic and clinical comparison between sodium hyaluronate (500-730 kDa) and methylprednisolone acetate. J Orthopaed Traumatol 2002;3:89-96
   Google Scholar
• Waddell DD. The tolerability of viscosupplementation: low incidence and clinical management of local adverse events. Curr Med Res Opin 2003;19:575-80
   PubMed Web of Science ®Google Scholar
• Waddell DD, Cefalu CA, Bricker DC. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis. Curr Med Res Opin 2003;19:499-507
   PubMed Web of Science ®Google Scholar
• Waddell DD, Cefalu CA, Bricker DC. A second course of hylan G-F 20 for the treatment of osteoarthritic knee pain: 12-month patient follow-up. J Knee Surg 2005;18:7-15
   PubMedGoogle Scholar
• Raynauld JP, Goldsmith CH, Bellamy N, et al. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Osteoarthritis Cartilage 2005;13:111-19
   PubMed Web of Science ®Google Scholar
• Kotz R, Kolarz G. Intra-articular hyaluronic acid: duration of effect and results of repeated treatment cycles. Am J Orthop 1999;28:5-7
   PubMedGoogle Scholar
• Kolarz G, Kotz R, Hochmayer I. Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin Arthritis Rheum 2003;32:310-19
   PubMed Web of Science ®Google Scholar
• Scali JJ. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee. A long term study. Eur J Rheumatol Inflamm 1995;15:57-62
   Google Scholar
• Synvisc® (hylan G-F 20) Product Information. Genzyme Biosurgery 2003
   Google Scholar
• Waddell DD, Bricker DC. Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review. J Surg Orthop Adv 2006;15:53-9
   PubMedGoogle Scholar
• Antman EM, Bennett JS, Daugherty A, et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115:1634-42
   PubMed Web of Science ®Google Scholar
• Wright JM. The double-edged sword of COX-2 selective NSAIDs. CMAJ 2002;167:1131-7
   PubMed Web of Science ®Google Scholar
• Hawkey CJ. Cox-2 inhibitors. Lancet 1999;353:307-14
   PubMed Web of Science ®Google Scholar
• Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000;284:1247-55
   Google Scholar
• McKenna F, Borenstein D, Wendt H, et al. Celecoxib versus diclofenac in the management of osteoarthritis of the knee. Scand J Rheumatol 2001;30:11-18
   PubMed Web of Science ®Google Scholar
• Lisse JR, Perlman M, Johansson G, et al. Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial. Ann Intern Med 2003;139:539-46
   PubMed Web of Science ®Google Scholar
• Eversmeyer W, Poland M, DeLapp RE, et al. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis. Am J Med 1993;95:10-18S
   Google Scholar
• Distel M, Mueller C, Bluhmki E, et al. Safety of meloxicam: a global analysis of clinical trials. Br J Rheumatol 1996;35:68-77
   PubMedGoogle Scholar
• Zhao SZ, Reynolds MW, Lejkowith J, et al. A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database. Clin Ther 2001;23:1478-91
   PubMed Web of Science ®Google Scholar
• Gambaro G, Perazella MA. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. J Intern Med 2003;253:643-52
   PubMed Web of Science ®Google Scholar
• Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000;343:1520-8
   PubMed Web of Science ®Google Scholar
• Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005;352:1092-102
   PubMed Web of Science ®Google Scholar
• Solomon SD, McMurray JJ, Pfeffer MA, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005;352:1071-80
   PubMed Web of Science ®Google Scholar
• Caldwell B, Aldington S, Weatherall M, et al. Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J R Soc Med 2006;99:132-40
   PubMed Web of Science ®Google Scholar
• Andersohn F, Suissa S, Garbe E. Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation 2006;113:1950-7
   PubMed Web of Science ®Google Scholar
• McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006;296:1633-44
   PubMed Web of Science ®Google Scholar
• White WB, West CR, Borer JS, et al. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials. Am J Cardiol 2007;99:91-8
   PubMed Web of Science ®Google Scholar
• Waddell DD, Bricker DC. Clinical experience of hylan G-F 20 efficacy in patients with knee osteoathritis from a large, othropedic practice. Arch Phys Med Rehabil 2003;84:19
   Google Scholar
• Adams ME, Atkinson MH, Lussier AJ, et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti- inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 1995;3:213-25
   PubMed Web of Science ®Google Scholar
• Lee S, Park D, Chmell SJ. Viscosupplementation with hylan G-F 20 (Synvisc®): pain and mobility observations from 74 consecutive patients. J Knee Surg 2004;17:73-7
   PubMedGoogle Scholar
• Jubb RW, Piva S, Beinat L, et al. A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract 2003;57:467-74
   PubMed Web of Science ®Google Scholar
• Christensen R, Astrup A, Bliddal H. Weight loss: the treatment of choice for knee osteoarthritis? A randomized trial. Osteoarthritis Cartilage 2005;13:20-7
   PubMed Web of Science ®Google Scholar
• Baker KR, Nelson ME, Felson DT, et al. The efficacy of home based progressive strength training in older adults with knee osteoarthritis: a randomized controlled trial. J Rheumatol 2001;28:1655-65
   PubMed Web of Science ®Google Scholar
• Penninx BW, Messier SP, Rejeski WJ, et al. Physical exercise and the prevention of disability in activities of daily living in older persons with osteoarthritis. Arch Intern Med 2001;161:2309-16
   PubMed Web of Science ®Google Scholar
• Thomas KS, Muir KR, Doherty M, et al. Home based exercise programme for knee pain and knee osteoarthritis: randomised controlled trial. BMJ 2002;325:752
   PubMed Web of Science ®Google Scholar
• Roddy E, Zhang W, Doherty M. Aerobic walking of strengthening exercise for osteoarthritis of the knee? A systematic review. Ann Rheum Dis 2005;64:544-8
   PubMed Web of Science ®Google Scholar
• McCarthy CJ, Mills PM, Pullen R, et al. Supplementing a home exercise programme with a class-based exercise programme is more effective than home exercise alone in the treatment of knee osteoarthritis. Rheumatology 2004;43:880-6
   PubMed Web of Science ®Google Scholar
• Messier SP, Loeser RF, Miller GD, et al. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial. Arthritis Rheum 2004;50:1501-10
   PubMed Web of Science ®Google Scholar
• Deyle GD, Henderson NE, Matekel RL, et al. Effectiveness of manual physical therapy and exercise in osteoarthritis of the knee. A randomized, controlled trial. Ann Intern Med 2000;132:173-81
   PubMed Web of Science ®Google Scholar
• Weigl M, Angst F, Stucki G, et al. Inpatient rehabilitation for hip or knee osteoarthritis: 2 year follow up study. Ann Rheum Dis 2004;63:360-8
   PubMed Web of Science ®Google Scholar
• Tetik S, Ones K, Tetik C. Efficacy of intra-articular hylan G-F 20 on osteoarthritis of the knee. Pain Clinic 2003;15:459-66
   Web of Science ®Google Scholar
• Huang MH, Yang RC, Lee CL, et al. Preliminary results of integrated therapy for patients with knee osteoarthritis. Arthritis Rheum 2005;53:812-20
   PubMed Web of Science ®Google Scholar
• Vad VB, Bhat AL, Sculco TP, et al. Management of knee osteoarthritis: knee lavage combined with hylan versus hylan alone. Arch Phys Med Rehabil 2003;84:634-7
   PubMed Web of Science ®Google Scholar
• Tascioglu F, Oner C. Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Clin Rheumatol 2003;22:112-7
   PubMed Web of Science ®Google Scholar
• Pietrogrande V, Melanotte PL, D’Agnolo B, et al. Hyaluronic acid versus methylprednisolone intra-articularly injected for treatment of osteoarthritis of the knee. Curr Ther Res 1991;50:691-701
   Web of Science ®Google Scholar
• Jones AC, Pattrick M, Doherty S, et al. Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthritis Cartilage 1995;3:269-73
   PubMed Web of Science ®Google Scholar
• Godwin M, Dawes M. Intra-articular steroid injections for painful knees: systematic review with meta-analysis. Can Fam Physician 2004;50:241-8
   PubMed Web of Science ®Google Scholar
• Dieppe P, Sathapatayavongs B, Jones HE, et al. Intra-articular steroids in osteoarthritis. Rheumatol Rehabil 1980;19:212-7
   PubMedGoogle Scholar
• Caldwell JR. Intra-articular corticosteroids. Guide to selection and indications for use. Drugs 1996;52:507-14
   Google Scholar
• Bellamy N, Campbell J, Robinson V, et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2005;2: CD005328
   Google Scholar
• Ozturk C, Atamaz F, Hepguler S, et al. The safety and efficacy of intraarticular hyaluronan with/without corticosteroid in knee osteoarthritis: 1-year, single-blind, randomized study. Rheum Int Clin Exper Investig 2005;26:314-9
   Google Scholar
• Gray RG, Gottlieb NL. Intra-articular corticosteroids. An updated assessment. Clin Orthop Relat Res 1983;177:235-63
   PubMedGoogle Scholar
• Bell M, Fallaha M, Lenczner E, et al. Viscosupplementation with hylan G-F 20 in total knee replacement candidates: an effective pain management therapy that may delay surgery. Osteoarthritis Cartilage 1999;7:30
   Google Scholar
• Waddell DD, Bricker DC. Total knee replacement delayed with hylan G-F 20 use in patients with grade IV osteoarthritis. J Manag Care Pharm 2007;13:113-21
   PubMed Web of Science ®Google Scholar
• Jackson DW, Evans NA, Thomas BM. Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am 2002;84:1522-7
   PubMed Web of Science ®Google Scholar